NEW PHTHALOCYANINES FOR PHOTODYNAMIC VIRUS INACTIVATION IN RED BLOOD CELL CONCENTRATES
- 1 August 1994
- journal article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 60 (2) , 165-170
- https://doi.org/10.1111/j.1751-1097.1994.tb05085.x
Abstract
Cationic phthalocyanines with either aluminum or silicon as the central metal were evaluated for their ability to inactivate viruses in red blood cell concentrates (RBCC) photodynamically. In addition, the virucidal potential of a substituted anionic phthalocyanine, aluminum dibenzodisulfophthalocyanine hydroxide (AlN2SB2POH) was evaluated and compared with that of the much studied anionic aluminum tetrasulfophthalocyanine hydroxide (AIPcS4OH). Based on the rate of inactivation of the lipid-enveloped vesicular stomatitisvirus (VSV), the viruci dal potential of these phthalocyanines was: HOSiPCOSi(CH3)2(CH2)3N+(CH3)3I- (Pc 5) = SiPC[OSi(CH3)2-(CH2)3N+(CH3)3I-]2 (Pc 6) > AIPCOSi(CH,)2(CH2)˜N+(CH3)2(CH˜)11CH3I- (Pc 21) = A1N2SB2POH = AlPcS4 > HOSiPc[OSi(CH3)2(CH2)3N+(CH3)2(CH2)11CH31–]2(Pc 14) > AIPcOSi(CH3)2(CH2)3N+(CHS)3I- (Pc 2). Phthalocy anine ligand 14 and Pc 21 are new phthalocyanines, made by quaternizing known amino analogues. Compared to VSV, the rate of inactivation of Sindbis virus (another model lipid-enveloped virus) was identical when treated in red blood cells (RBC) with Pc 5 and slightly higher when treated with Pc 6 and AlPcS4OH. Treatment of RBCC containing cell-free human immunodeficiency virus (HIV-1) with Pc 5 or AlPcS4OH required 15 min of irradiation to inactivate (>5 log10 reduction) the virus. The extent of HIV-1 inactivation with AlN2SB2POH was 3.7 log10 after 60 min of red light exposure. The RBC integrity after photosensitization was measured by the ability of the cells to bind to plates coated with poly-L-lysine, (which reflects the retention of the RBC surface negative charges) and hemolysis of the cells over a 7 day storage period. The RBC damage using these criteria was most pronounced with Pc 5 and Pc 6 but could be reduced when treatment was in plasma instead of buffer. These data indicate that lipid-enveloped viruses differ in their sensitivity to phthalocyanine photosensitization. Therefore, for virus sterilization of RBCC for transfusion the ability to inactivate human pathogenic viruses completely will have to be evaluated for each virus. The cationic Pc 5 appears to be a potentially useful virucidal agent.Keywords
This publication has 17 references indexed in Scilit:
- New trends in photobiology: Photosensitizers as virucidal agentsJournal of Photochemistry and Photobiology B: Biology, 1993
- Photodynamic properties of naphthosulfobenzoporphyrazines, novel asymmetric, amphiphilic phthalocyanine derivativesJournal of Photochemistry and Photobiology B: Biology, 1992
- Virus sterilization in platelet concentrates with psoralen and ultraviolet A light in the presence of quenchersTransfusion, 1992
- Photodynamic inactivation of retroviruses by phthalocyanines: The effects of sulphonation, metal ligand and fluorideJournal of Photochemistry and Photobiology B: Biology, 1992
- Preliminary studies of photoinactivation of human immunodeficiency virus in bloodTransfusion, 1991
- Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen‐ultraviolet A and merocyanine 540‐visible light methodsTransfusion, 1991
- Inhibition by albumin of merocyanine 540‐mediated photosensitization of platelets and virusesTransfusion, 1991
- Inactivation of viruses in blood with aluminum phthalocyanine derivativesTransfusion, 1991
- Development of a model to demonstrate photosensitizer‐mediated viral inactivation in bloodTransfusion, 1990
- Photodynamic therapy of viral contaminants with potential for blood banking applicationsTransfusion, 1988